Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine kinase activity	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3 ATM	9.26e-06	363	163	13	GO:0106310
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF597 ZNF765 ZNF311 ZNF146 ZFP3 MYOD1 ZNF722 ISX ZNF772 ZNF619 SIM1 SIM2 ZNF835 ZNF17 ZNF713 ZNF497 ZNF792 ZNF41 PAX8 ZNF566 ZNF70 ZNF888 ZNF552 ZNF770 HSF2 ZNF649 ZNF697	5.11e-05	1459	163	27	GO:0000977
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3 ATM	7.84e-05	446	163	13	GO:0004674
GeneOntologyMolecularFunction	N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity	CHSY1 CHSY3	3.93e-04	4	163	2	GO:0050510
GeneOntologyMolecularFunction	protein kinase activity	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 TEK MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3 ATM	4.18e-04	600	163	14	GO:0004672
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF597 ZNF765 ZNF311 ZNF146 ZFP3 MYOD1 ZNF722 ISX ZNF772 ZNF619 SIM1 SIM2 ZNF17 ZNF713 ZNF792 ZNF41 PAX8 ZNF566 ZNF70 ZNF888 ZNF552 ZNF770 HSF2 ZNF697	4.91e-04	1412	163	24	GO:0000981
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	RASGRF1 RASGRF2 RIN1 SBF2 DOCK7 RAPGEF2 SMCR8 FGD6	6.35e-04	231	163	8	GO:0005085
GeneOntologyMolecularFunction	ferric-chelate reductase (NADPH) activity	STEAP2 STEAP1	6.52e-04	5	163	2	GO:0052851
GeneOntologyMolecularFunction	ferric-chelate reductase activity	STEAP2 STEAP1	6.52e-04	5	163	2	GO:0000293
GeneOntologyMolecularFunction	cupric reductase (NADH) activity	STEAP2 STEAP1	6.52e-04	5	163	2	GO:0008823
GeneOntologyMolecularFunction	glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity	CHSY1 CHSY3	9.72e-04	6	163	2	GO:0047238
GeneOntologyMolecularFunction	protein tyrosine kinase activity	RPS6KA5 CLK4 RIPK2 TEK NEK1 CLK3	1.23e-03	145	163	6	GO:0004713
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF597 ZNF765 ZNF311 ZNF146 ZFP3 MYOD1 ZNF722 ZNF772 ZNF835 ZNF17 ZNF713 ZNF497 ZNF792 ZNF41 PAX8 ZNF888 ZNF552 ZNF770 HSF2 ZNF649 ZNF697	1.24e-03	1244	163	21	GO:0000978
GeneOntologyMolecularFunction	MutSalpha complex binding	MCM8 MLH1	1.35e-03	7	163	2	GO:0032407
GeneOntologyMolecularFunction	oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor	STEAP2 STEAP1	1.35e-03	7	163	2	GO:0016723
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF597 ZNF765 ZNF311 ZNF146 ZFP3 MYOD1 ZNF722 ZNF772 ZNF835 ZNF17 ZNF713 ZNF497 ZNF792 ZNF41 PAX8 ZNF888 ZNF552 ZNF770 HSF2 ZNF649 ZNF697	1.61e-03	1271	163	21	GO:0000987
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CDK17 RPS6KA5 CAMK2G SPEG CLK4 TUT7 RIPK2 PARP14 TEK MAP3K5 NUAK2 NEK1 CLK3 GYS1 STK33 MAPKAPK3 ATM	1.75e-03	938	163	17	GO:0016772
Domain	Znf_C2H2/integrase_DNA-bd	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF713 ZNF497 ZNF532 ZNF792 ZNF41 ZNF566 ZNF70 ZNF552 ZNF770 ZNF649 ZNF687 ZNF697	1.33e-09	694	161	25	IPR013087
Domain	ZINC_FINGER_C2H2_1	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 TUT7 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF713 ZNF497 ZNF532 ZNF792 ZNF41 ZNF566 ZNF70 ZNF552 ZNF770 ZNF649 ZNF687 ZNF697	2.81e-09	777	161	26	PS00028
Domain	Znf_C2H2	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 TUT7 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF713 ZNF497 ZNF532 ZNF792 ZNF41 ZNF566 ZNF70 ZNF552 ZNF770 ZNF649 ZNF687 ZNF697	5.85e-09	805	161	26	IPR007087
Domain	zf-C2H2	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF713 ZNF497 ZNF792 ZNF41 ZNF566 ZNF70 ZNF552 ZNF770 ZNF649 ZNF687 ZNF697	6.35e-09	693	161	24	PF00096
Domain	ZINC_FINGER_C2H2_2	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF713 ZNF497 ZNF532 ZNF792 ZNF41 ZNF566 ZNF70 ZNF552 ZNF770 ZNF649 ZNF687 ZNF697	1.22e-08	775	161	25	PS50157
Domain	-	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF497 ZNF532 ZNF792 ZNF41 ZNF566 ZNF70 ZNF552 ZNF770 ZNF649 ZNF697	2.05e-08	679	161	23	3.30.160.60
Domain	Znf_C2H2-like	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF713 ZNF497 ZNF532 ZNF792 ZNF41 ZNF566 ZNF70 ZNF552 ZNF770 ZNF649 ZNF687 ZNF697	2.07e-08	796	161	25	IPR015880
Domain	ZnF_C2H2	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF713 ZNF497 ZNF532 ZNF792 ZNF41 ZNF566 ZNF70 ZNF552 ZNF770 ZNF649 ZNF687 ZNF697	2.77e-08	808	161	25	SM00355
Domain	KRAB	ZNF597 ZNF765 ZNF311 ZNF234 ZNF214 ZNF772 ZNF230 ZNF235 ZNF17 ZNF713 ZNF792 ZNF41 ZNF566 ZNF552 ZNF649	5.08e-07	358	161	15	PS50805
Domain	KRAB	ZNF597 ZNF765 ZNF311 ZNF234 ZNF214 ZNF772 ZNF230 ZNF235 ZNF17 ZNF713 ZNF792 ZNF41 ZNF566 ZNF552 ZNF649	5.08e-07	358	161	15	PF01352
Domain	KRAB	ZNF597 ZNF765 ZNF311 ZNF234 ZNF214 ZNF772 ZNF230 ZNF235 ZNF17 ZNF713 ZNF792 ZNF41 ZNF566 ZNF552 ZNF649	7.44e-07	369	161	15	SM00349
Domain	KRAB	ZNF597 ZNF765 ZNF311 ZNF234 ZNF214 ZNF772 ZNF230 ZNF235 ZNF17 ZNF713 ZNF792 ZNF41 ZNF566 ZNF552 ZNF649	7.69e-07	370	161	15	IPR001909
Domain	S_TKc	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 TEK MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3	1.45e-05	359	161	13	SM00220
Domain	zf-C2H2_6	ZNF597 ZNF765 ZNF311 ZNF234 ZNF619 ZNF17 ZNF497 ZNF532 ZNF792 ZNF566 ZNF770 ZNF649	1.84e-05	314	161	12	PF13912
Domain	Kinase-like_dom	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 TEK MAP3K5 NUAK2 NEK1 PTPN13 DST CLK3 STK33 MAPKAPK3 ATM	1.89e-05	542	161	16	IPR011009
Domain	Ser/Thr_kinase_AS	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3	6.42e-05	357	161	12	IPR008271
Domain	PROTEIN_KINASE_ST	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3	7.33e-05	362	161	12	PS00108
Domain	SIM_C	SIM1 SIM2	7.39e-05	2	161	2	IPR010578
Domain	SIM_C	SIM1 SIM2	7.39e-05	2	161	2	PF06621
Domain	SIM_C	SIM1 SIM2	7.39e-05	2	161	2	PS51302
Domain	Protein_kinase_ATP_BS	CDK17 RPS6KA5 CAMK2G SPEG CLK4 TEK MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3	1.13e-04	379	161	12	IPR017441
Domain	Pkinase	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3	1.19e-04	381	161	12	PF00069
Domain	PROTEIN_KINASE_ATP	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 TEK MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3	1.77e-04	459	161	13	PS00107
Domain	VPS13	VPS13C VPS13D	2.20e-04	3	161	2	IPR026847
Domain	VPS13_mid_rpt	VPS13C VPS13D	2.20e-04	3	161	2	PF16910
Domain	VPS13	VPS13C VPS13D	2.20e-04	3	161	2	PF16908
Domain	VPS13_N2	VPS13C VPS13D	2.20e-04	3	161	2	IPR031646
Domain	VPS13_mid_rpt	VPS13C VPS13D	2.20e-04	3	161	2	IPR031642
Domain	Prot_kinase_dom	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 TEK MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3	3.27e-04	489	161	13	IPR000719
Domain	PROTEIN_KINASE_DOM	CDK17 RPS6KA5 CAMK2G SPEG CLK4 RIPK2 TEK MAP3K5 NUAK2 NEK1 CLK3 STK33 MAPKAPK3	3.54e-04	493	161	13	PS50011
Domain	SHR-BD	VPS13C VPS13D	4.38e-04	4	161	2	IPR009543
Domain	VPS13_C	VPS13C VPS13D	4.38e-04	4	161	2	PF16909
Domain	VPS13_C	VPS13C VPS13D	4.38e-04	4	161	2	IPR031645
Domain	SHR-BD	VPS13C VPS13D	4.38e-04	4	161	2	PF06650
Domain	RasGEFN	RASGRF1 RASGRF2 RAPGEF2	6.43e-04	20	161	3	SM00229
Domain	RasGEF_N	RASGRF1 RASGRF2 RAPGEF2	7.46e-04	21	161	3	PF00618
Domain	Ras-like_Gua-exchang_fac_N	RASGRF1 RASGRF2 RAPGEF2	8.58e-04	22	161	3	IPR000651
Domain	RASGEF_NTER	RASGRF1 RASGRF2 RAPGEF2	8.58e-04	22	161	3	PS50212
Domain	-	CUBN CDCP1 MEGF8 SEZ6	1.04e-03	52	161	4	2.60.120.290
Domain	CUB	CUBN CDCP1 MEGF8 SEZ6	1.12e-03	53	161	4	PS01180
Domain	CUB_dom	CUBN CDCP1 MEGF8 SEZ6	1.47e-03	57	161	4	IPR000859
Domain	TUDOR	TDRD9 ARID4A RNF17	1.58e-03	27	161	3	SM00333
Domain	CYCLINS	CCNT1 CCNE2 CCNI	1.76e-03	28	161	3	PS00292
Domain	RASGEF_CAT	RASGRF1 RASGRF2 RAPGEF2	1.95e-03	29	161	3	PS50009
Domain	Chond_GalNAc	CHSY1 CHSY3	2.00e-03	8	161	2	IPR008428
Domain	Chorein_N	VPS13C VPS13D	2.00e-03	8	161	2	PF12624
Domain	CHGN	CHSY1 CHSY3	2.00e-03	8	161	2	PF05679
Domain	VPS13_N	VPS13C VPS13D	2.00e-03	8	161	2	IPR026854
Domain	RasGEF	RASGRF1 RASGRF2 RAPGEF2	2.15e-03	30	161	3	PF00617
Domain	-	RASGRF1 RASGRF2 RAPGEF2	2.15e-03	30	161	3	1.10.840.10
Domain	RASGEF_cat_dom	RASGRF1 RASGRF2 RAPGEF2	2.15e-03	30	161	3	IPR001895
Domain	Tudor	TDRD9 ARID4A RNF17	2.15e-03	30	161	3	IPR002999
Domain	RasGEF	RASGRF1 RASGRF2 RAPGEF2	2.15e-03	30	161	3	SM00147
Domain	Ras_GEF_dom	RASGRF1 RASGRF2 RAPGEF2	2.15e-03	30	161	3	IPR023578
Domain	zf-C2H2_11	ZNF532 ZNF687	2.55e-03	9	161	2	PF16622
Domain	Cyclin_N	CCNT1 CCNE2 CCNI	2.84e-03	33	161	3	PF00134
Domain	Cyclin_N	CCNT1 CCNE2 CCNI	2.84e-03	33	161	3	IPR006671
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	ZNF597 GAD1 ZNF311 THOC7 ZNF234 CAMK2G TSC1 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 CCNT1 ZNF17 ZNF713 PSME4 ZNF792 ZNF41 CCNE2 ZNF566 MLH1 ZNF70 ZNF552 ZNF770 ATM ZNF649 CDC27 MED13 ZNF697	2.59e-06	1387	118	29	M734
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 USP53 VPS13C HECTD4 CHSY1 ERI2 NUAK2 KANSL3 DST PSME4 USP38 ZNF532 NBEAL2 SENP6 MED13 ZNF687	6.63e-09	529	167	16	14621295
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 USP53 CDK17 ZNF146 CALU RIPK2 LUZP1 NUAK2 NEK1 VPS13D PTPN13 DST MEGF8 AASS CLK3 DOCK7 RAPGEF2 FGD6 SAMD4A ARHGAP19	7.05e-09	861	167	20	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PNPLA2 ITPRIPL2 ATP13A1 SPEG HECTD4 CHSY1 SIAH2 PLXNB2 MAP3K5 KANSL3 BMP4 DST PSME4 MEGF8 SH3TC1 ADAMTS7 INF2 PLA2G4B NBEAL2 SBF2 MED13 ZNF687	1.89e-08	1105	167	22	35748872
Pubmed	A GO catalogue of human DNA-binding transcription factors.	ZNF234 ZNF214 ZNF230 ZNF235 ZNF532 ZNF687	5.09e-08	42	167	6	34673265
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF311 ZNF235 ZNF17 ZNF792 ZNF41 ZNF566 ZNF552 ZNF649 ZNF697	2.53e-07	181	167	9	37372979
Pubmed	Sim1 and Sim2 expression during chick and mouse limb development.	MYOD1 SIM1 SIM2	4.33e-07	4	167	3	19123137
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 USP53 CACNA1C DPP6 MCM8 VPS45 VPS13C HECTD4 STEAP2 KANSL3 CNNM4 PPP2R3A PTPN13 SH3TC1 ZNF532 INF2 MICAL2 GLYR1 SBF2 LMLN SEL1L3 RAPGEF2 STEAP1	8.06e-07	1489	167	23	28611215
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	RALGAPA1 CENPF DHX40 CCNT1 DST AASS CLK3 MARF1	5.39e-06	197	167	8	20811636
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	CDK17 ZNF146 VPS45 ZYG11B LUZP1 CNNM4 RIN1 NEK1 PTPN13 LMAN1 WDCP GYS1 MARF1 DOCK7 AIPL1 SPAG16 CDC27 FGD6 STEAP1 ARHGAP19	6.03e-06	1321	167	20	27173435
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	CENPF CAMK2G LUZP1 NEK1 PTPN13 DST LMAN1 ZNF532 WDCP DOCK7 ZNF687	6.26e-06	418	167	11	34709266
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	RPS6KA5 CAMK2G CLK4 RIPK2 LUZP1 NUAK2 CCNT1 NEK1 DST CLK3 CCNE2 STK33 CPLANE1 CDC27 CCNI ZNF687	8.91e-06	910	167	16	36736316
Pubmed	RASGRF2 controls nuclear migration in postnatal retinal cone photoreceptors.	RASGRF1 RASGRF2	2.29e-05	2	167	2	26743081
Pubmed	Metabotropic glutamate receptors drive global persistent inhibition in the visual thalamus.	GAD1 GRM5	2.29e-05	2	167	2	23392677
Pubmed	Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression.	RASGRF1 RASGRF2	2.29e-05	2	167	2	16467520
Pubmed	Cloning of two human homologs of the Drosophila single-minded gene SIM1 on chromosome 6q and SIM2 on 21q within the Down syndrome chromosomal region.	SIM1 SIM2	2.29e-05	2	167	2	9199934
Pubmed	Single-minded--two genes, three chromosomes.	SIM1 SIM2	2.29e-05	2	167	2	9199929
Pubmed	The environment versus genetics in controlling the contribution of MAP kinases to synaptic plasticity.	RASGRF1 RASGRF2	2.29e-05	2	167	2	17141611
Pubmed	Overexpression of mSim2 gene in the zona limitans of the diencephalon of segmental trisomy 16 Ts1Cje fetuses, a mouse model for trisomy 21: a novel whole-mount based RNA hybridization study.	SIM1 SIM2	2.29e-05	2	167	2	10837894
Pubmed	Mutation screening of BMP4 and Id2 genes in Chinese patients with congenital ureteropelvic junction obstruction.	ID2 BMP4	2.29e-05	2	167	2	21927809
Pubmed	Chondroitin sulfate synthase-3. Molecular cloning and characterization.	CHSY1 CHSY3	2.29e-05	2	167	2	12907687
Pubmed	Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.	MLH1 ATM	2.29e-05	2	167	2	20709753
Pubmed	Transgenerational rescue of a genetic defect in long-term potentiation and memory formation by juvenile enrichment.	RASGRF1 RASGRF2	2.29e-05	2	167	2	19193896
Pubmed	Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors.	RASGRF1 RASGRF2	2.29e-05	2	167	2	14749369
Pubmed	BMP4 regulates pancreatic progenitor cell expansion through Id2.	ID2 BMP4	2.29e-05	2	167	2	16547003
Pubmed	Genome-wide homozygosity mapping in families with leber congenital amaurosis identifies mutations in AIPL1 and RDH12 genes.	RDH12 AIPL1	2.29e-05	2	167	2	25148430
Pubmed	A murine CDC25/ras-GRF-related protein implicated in Ras regulation.	RASGRF1 RASGRF2	2.29e-05	2	167	2	8293576
Pubmed	Ras-GRF2 regulates nestin-positive stem cell density and onset of differentiation during adult neurogenesis in the mouse dentate gyrus.	RASGRF1 RASGRF2	2.29e-05	2	167	2	28966131
Pubmed	A novel nuclear localization signal in the human single-minded proteins SIM1 and SIM2.	SIM1 SIM2	2.29e-05	2	167	2	14697214
Pubmed	The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice.	RASGRF1 RASGRF2	2.29e-05	2	167	2	31182637
Pubmed	Metabotropic glutamate receptor type 5-dependent long-term potentiation of excitatory synapses on fast-spiking GABAergic neurons in mouse visual cortex.	GAD1 GRM5	2.29e-05	2	167	2	18234900
Pubmed	Malignant transformation of multipotent muscle-derived cells by concurrent differentiation signals.	MYOD1 BMP4	2.29e-05	2	167	2	17569791
Pubmed	DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma.	MLH1 DLEC1	2.29e-05	2	167	2	18594535
Pubmed	ASKA technology-based pull-down method reveals a suppressive effect of ASK1 on the inflammatory NOD-RIPK2 pathway in brown adipocytes.	RIPK2 MAP3K5	2.29e-05	2	167	2	34759307
Pubmed	A two-hybrid assay to study protein interactions within the secretory pathway.	MYOD1 ID2	2.29e-05	2	167	2	21209940
Pubmed	Epaxial-adaxial-hypaxial regionalisation of the vertebrate somite: evidence for a somitic organiser and a mirror-image duplication.	MYOD1 SIM1 BMP4	3.00e-05	13	167	3	11455436
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CACNA1C RASGRF2 CENPF SPEG ABHD10 RIPK2 TSC1 VPS13D NBEAL2 ATM ZNF687	3.10e-05	497	167	11	36774506
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RALGAPA1 VPS45 VPS13C TSC1 VPS13D PTPN13 DST LMAN1 MEGF8 INF2 SMCR8	3.52e-05	504	167	11	34432599
Pubmed	Ras-specific exchange factor GRF: oligomerization through its Dbl homology domain and calcium-dependent activation of Raf.	RASGRF1 RASGRF2 CAMK2G	3.81e-05	14	167	3	10373510
Pubmed	The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1.	RASGRF1 RASGRF2 CAMK2G	4.74e-05	15	167	3	14622581
Pubmed	Defining the membrane proteome of NK cells.	MYO1C ATP13A1 CALU CAMK2G CHSY1 PARP14 ADAM10 LUZP1 LMAN1 CLK3 NBEAL2 GYS1 MARF1 MLH1 HECA MED13 STEAP1	5.11e-05	1168	167	17	19946888
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RALGAPA1 CDK17 LUZP1 PTPN13 DST DOCK7 CEP295 RAPGEF2 SAMD4A XPR1	6.42e-05	446	167	10	24255178
Pubmed	Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.	CCNT1 RNF123 SBF2 DOCK7 MLH1	6.46e-05	87	167	5	17148452
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	MXRA5 CALU DHX40 CAMK2G RNF123 MEGF8 AASS GYS1 NFKBIB CEP295 SMCR8 ZNF687	6.51e-05	638	167	12	31182584
Pubmed	RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation.	RASGRF1 RASGRF2	6.85e-05	3	167	2	21685891
Pubmed	Chondroitin synthase-3 regulates nucleus pulposus degeneration through actin-induced YAP signaling.	CHSY1 CHSY3	6.85e-05	3	167	2	33089528
Pubmed	Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development.	RASGRF1 RASGRF2	6.85e-05	3	167	2	11909944
Pubmed	Physical mapping of the holoprosencephaly critical region in 21q22.3, exclusion of SIM2 as a candidate gene for holoprosencephaly, and mapping of SIM2 to a region of chromosome 21 important for Down syndrome.	SIM1 SIM2	6.85e-05	3	167	2	7485157
Pubmed	cDNA cloning of a murine homologue of Drosophila single-minded, its mRNA expression in mouse development, and chromosome localization.	SIM1 SIM2	6.85e-05	3	167	2	8561800
Pubmed	The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer.	STEAP2 STEAP1	6.85e-05	3	167	2	32802887
Pubmed	Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells.	RASGRF1 ATM	6.85e-05	3	167	2	17611684
Pubmed	Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB.	RASGRF1 RASGRF2	6.85e-05	3	167	2	15029245
Pubmed	BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/CDKN1B signaling.	ID2 BMP4	6.85e-05	3	167	2	28543546
Pubmed	Small suitability of the DLEC1, MLH1 and TUSC4 mRNA expression analysis as potential prognostic or differentiating markers for NSCLC patients in the Polish population.	MLH1 DLEC1	6.85e-05	3	167	2	28674222
Pubmed	Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer.	STEAP2 STEAP1	6.85e-05	3	167	2	12095985
Pubmed	Primary Congenital Glaucoma	TEK LTBP2	6.85e-05	3	167	2	20301314
Pubmed	Characterization of human variants in obesity-related SIM1 protein identifies a hot-spot for dimerization with the partner protein ARNT2.	SIM1 SIM2	6.85e-05	3	167	2	24814368
Pubmed	Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.	MLH1 ATM	6.85e-05	3	167	2	16150740
Pubmed	Repair genes expression profile of MLH1, MSH2 and ATM in the normal oral mucosa of chronic smokers.	MLH1 ATM	6.85e-05	3	167	2	27693945
Pubmed	ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition.	SIM2 ATM	6.85e-05	3	167	2	30531838
Pubmed	Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer.	MLH1 DLEC1	6.85e-05	3	167	2	27287342
Pubmed	Six-transmembrane epithelial antigen of the prostate (STEAP1 and STEAP2)-differentially expressed by murine and human mesenchymal stem cells.	STEAP2 STEAP1	6.85e-05	3	167	2	19196137
Pubmed	Characterization of msim, a murine homologue of the Drosophila sim transcription factor.	SIM1 SIM2	6.85e-05	3	167	2	8661115
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	CENPF ZNF230 ZNF17 DST CEP295 CCNI	9.39e-05	151	167	6	17043677
Pubmed	Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite.	MYOD1 SIM1 BMP4	9.96e-05	19	167	3	9585504
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	USP53 VPS13C SPEG KANSL3 FGD6 ZNF687	1.01e-04	153	167	6	10718198
Pubmed	Differential expansion of zinc-finger transcription factor loci in homologous human and mouse gene clusters.	ZNF234 ZNF230 ZNF235	1.17e-04	20	167	3	12743021
Pubmed	Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.	ID2 PAX8	1.37e-04	4	167	2	11134340
Pubmed	Evidence of STAT1 phosphorylation modulated by MAPKs, MEK1 and MSK1.	RPS6KA5 CAMK2G	1.37e-04	4	167	2	14963018
Pubmed	Structural and spatial determinants regulating TC21 activation by RasGRF family nucleotide exchange factors.	RASGRF1 RASGRF2	1.37e-04	4	167	2	19692568
Pubmed	Cardiotrophin-1 stimulates lipolysis through the regulation of main adipose tissue lipases.	PNPLA2 CTF1	1.37e-04	4	167	2	25351614
Pubmed	ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation.	ADAM10 CTF1	1.37e-04	4	167	2	15958533
Pubmed	An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss.	TSC1 PAX8	1.37e-04	4	167	2	36357396
Pubmed	Anaphase-promoting complex/cyclosome participates in the acute response to protein-damaging stress.	HSF2 CDC27	1.37e-04	4	167	2	20937767
Pubmed	RasGRF Couples Nox4-Dependent Endoplasmic Reticulum Signaling to Ras.	RASGRF1 RASGRF2	1.37e-04	4	167	2	27856453
Pubmed	Chondroitin synthases I, II, III and chondroitin sulfate glucuronyltransferase expression in colorectal cancer.	CHSY1 CHSY3	1.37e-04	4	167	2	21468578
Pubmed	P-TEFb is degraded by Siah1/2 in quiescent cells.	SIAH2 CCNT1	1.37e-04	4	167	2	35524561
Pubmed	ATM controls meiotic double-strand-break formation.	MLH1 ATM	1.37e-04	4	167	2	22002603
Pubmed	Ras-guanine-nucleotide-releasing factors 1 and 2 interact with PLCγ at focal adhesions to enable IL-1-induced Ca(2+) signalling, ERK activation and MMP-3 expression.	RASGRF1 RASGRF2	1.37e-04	4	167	2	23145787
Pubmed	Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase.	RPS6KA5 MAPKAPK3	1.37e-04	4	167	2	11335727
Pubmed	Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression.	MYOD1 ID2	1.37e-04	4	167	2	10915743
Pubmed	Analysis of the human VPS13 gene family.	VPS13C VPS13D	1.37e-04	4	167	2	15498460
Pubmed	Members of the bHLH-PAS family regulate Shh transcription in forebrain regions of the mouse CNS.	SIM1 SIM2	1.37e-04	4	167	2	11023872
Pubmed	The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins.	MYOD1 ID2	1.37e-04	4	167	2	11940648
Pubmed	Determinants of helix-loop-helix dimerization affinity. Random mutational analysis of SCL/tal.	MYOD1 ID2	1.37e-04	4	167	2	8576241
Pubmed	Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor.	SENP6 HSF2	1.37e-04	4	167	2	11278381
Pubmed	Characterization and comparison of four serine- and arginine-rich (SR) protein kinases.	CLK4 CLK3	1.37e-04	4	167	2	9307018
Pubmed	Predictive potential of STEAP family for survival, immune microenvironment and therapy response in glioma.	STEAP2 STEAP1	1.37e-04	4	167	2	34649092
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TUT7 ZYG11B SBF2 DOCK7 CEP295	1.38e-04	102	167	5	11214970
Pubmed	Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases.	USP53 USP44 USP38	1.79e-04	23	167	3	14715245
Pubmed	Human transcription factor protein interaction networks.	THOC7 REXO4 ZNF146 MYO1C ARID4A CALU MYOD1 DHX40 ISX KANSL3 DST PAX8 WDCP GLYR1 NFKBIB MARF1 ZNF770 ZNF687	1.89e-04	1429	167	18	35140242
Pubmed	Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module.	ID2 BMP4 PPP2R3A DST LTBP2 ATM	2.23e-04	177	167	6	22560297
Pubmed	BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling.	TEK BMP4	2.27e-04	5	167	2	18006519
Pubmed	Role of p38alpha Map kinase in Type I interferon signaling.	RPS6KA5 MAPKAPK3	2.27e-04	5	167	2	14578350
Pubmed	The Steap proteins are metalloreductases.	STEAP2 STEAP1	2.27e-04	5	167	2	16609065
Pubmed	ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.	MLH1 ATM	2.27e-04	5	167	2	15226443
Pubmed	Sam68 marks the transcriptionally active stages of spermatogenesis and modulates alternative splicing in male germ cells.	MLH1 ATM	2.27e-04	5	167	2	21355037
Pubmed	Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins.	BMP4 DOCK7	2.27e-04	5	167	2	22158624
Pubmed	Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities.	USP44 CDC27	2.27e-04	5	167	2	17443180
Pubmed	Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate.	STEAP2 STEAP1	2.27e-04	5	167	2	12429817
Pubmed	OUT, a novel basic helix-loop-helix transcription factor with an Id-like inhibitory activity.	MYOD1 ID2	2.27e-04	5	167	2	10652346
Interaction	YWHAB interactions	RALGAPA1 CDK17 ZNF146 RASGRF1 CAMK2G SPEG HECTD4 RIPK2 TSC1 LUZP1 MAP3K5 RIN1 NEK1 VPS13D LRFN4 PTPN13 DST AASS CLK3 DOCK7 RAPGEF2 FGD6 SAMD4A ARHGAP19	2.21e-06	1014	163	24	int:YWHAB
Interaction	YWHAH interactions	RALGAPA1 USP53 CDK17 ZNF146 CAMK2G SPEG HECTD4 RIPK2 TSC1 LUZP1 MAP3K5 NUAK2 RIN1 NEK1 VPS13D PTPN13 DST MEGF8 AASS CLK3 DOCK7 RAPGEF2 FGD6 SAMD4A ARHGAP19	2.82e-06	1102	163	25	int:YWHAH
Interaction	YWHAZ interactions	RALGAPA1 CDK17 ZNF146 RASGRF1 RPS6KA5 RASGRF2 CAMK2G SPEG HECTD4 TSC1 LUZP1 MAP3K5 NUAK2 RIN1 NEK1 VPS13D PTPN13 DST AASS CLK3 NBEAL2 DOCK7 ATM RAPGEF2 FGD6 SAMD4A ARHGAP19	7.30e-06	1319	163	27	int:YWHAZ
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF765 ZNF146 ZNF234 ZNF772 ZNF230 ZNF235 ZNF835 ZNF17 ZNF497 MEGF8 ZNF792 GYS1 NFKBIB ZNF566 ZNF888 ZNF552 ZNF649 ASPDH	4.11e-07	1192	167	18	chr19q13
Cytoband	19q13.43	ZNF772 ZNF835 ZNF497 ZNF552	2.97e-04	87	167	4	19q13.43
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF597 ZNF765 ZNF311 ZNF146 ZNF234 ZFP3 ZNF214 ZNF772 ZNF619 ZNF230 ZNF235 ZNF835 ZNF17 ZNF713 ZNF497 ZNF532 ZNF792 ZNF41 ZNF566 ZNF70 ZNF888 ZNF552 ZNF770 ZNF649 ZNF697	8.93e-12	718	121	25	28
GeneFamily	CDC like kinases	CLK4 CLK3	2.64e-04	4	121	2	480
GeneFamily	Proteases, serine\|STEAP family	STEAP2 STEAP1	4.38e-04	5	121	2	1324
GeneFamily	Cyclins	CCNT1 CCNE2 CCNI	8.48e-04	28	121	3	473
GeneFamily	Mitogen-activated protein kinase-activated protein kinases	RPS6KA5 MAPKAPK3	2.35e-03	11	121	2	1156
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DPP6 CUBN PPP2R3A PTPN13 PAX8 GLDC STK33 ATP6V0A4 CACNA2D3	4.83e-08	193	166	9	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SIM1 SIM2 PPP2R3A PTPN13 PAX8 STK33 ATP6V0A4 SPAG16 CACNA2D3	5.05e-08	194	166	9	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SIM1 PPP2R3A PTPN13 PAX8 GLDC STK33 ATP6V0A4 SPAG16 CACNA2D3	5.05e-08	194	166	9	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SIM1 SIM2 PPP2R3A PTPN13 PAX8 STK33 ATP6V0A4 SPAG16 CACNA2D3	5.52e-08	196	166	9	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ZNF146 ARID4A LUZP1 VPS13D ZNF41 MARF1 ZNF770 CEP295	5.07e-07	186	166	8	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	COVID-19-kidney\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DPP6 SIM1 CUBN PPP2R3A PAX8 GLDC ATP6V0A4 CACNA2D3	5.28e-07	187	166	8	d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell	COVID-19-kidney-CD-PC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIM1 FREM1 PPP2R3A PTPN13 PAX8 GLDC ATP6V0A4 SPAG16	5.49e-07	188	166	8	8f9996c3f3b27efaaae8960a66af77412de9c7ef
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	RIPK2 PARP14 STEAP2 CDCP1 PLXNB2 ADAM10 RIN1 STEAP1	6.44e-07	192	166	8	4e689bca7a242f8482e25f273656e2caba8821c0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPP6 CUBN PPP2R3A PTPN13 PAX8 GLDC STK33 ATP6V0A4	6.70e-07	193	166	8	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SIM1 SIM2 PPP2R3A PTPN13 PAX8 STK33 SPAG16 CACNA2D3	7.24e-07	195	166	8	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SIM1 SIM2 PPP2R3A PTPN13 PAX8 STK33 ATP6V0A4 CACNA2D3	7.53e-07	196	166	8	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	DPP6 RASGRF2 RIPK2 ZNF214 ERI2 SMYD4 PTPN13 SEL1L3	8.76e-07	200	166	8	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1C TNFAIP8L2 PNPLA2 MAP3K5 SH3TC1 RAPGEF2 HECA	3.99e-06	173	166	7	20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 FREM1 PTPN13 PAX8 GLDC STK33 DOCK7	5.57e-06	182	166	7	f96095b81188b52db8fcfca4837129cfcd9bd7b7
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRF2 ERI2 TEK KANSL3 PTPN13 SLC9A5 LRRD1	6.20e-06	185	166	7	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SIM2 PPP2R3A PAX8 STK33 SPAG16 CACNA2D3 SAMD4A	6.89e-06	188	166	7	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	CACNA1C PPP2R3A DST STK33 CACNA2D3 SAMD4A XPR1	7.38e-06	190	166	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	USP53 FREM1 PTPN13 PAX8 NBEAL2 STK33 ATP6V0A4	7.64e-06	191	166	7	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	COVID-19-kidney-TAL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GAD1 SIM1 SIM2 PPP2R3A PAX8 ATP6V0A4 CACNA2D3	7.64e-06	191	166	7	fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell	COVID-19-kidney-CNT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIM1 FREM1 PPP2R3A PTPN13 PAX8 GLDC ATP6V0A4	7.90e-06	192	166	7	760c6b9628de9693034b00c5025c5c4df94bb2e8
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RALGAPA1 USP38 SBF2 ZNF770 CPLANE1 SMCR8 MED13	8.18e-06	193	166	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SIM2 CDCP1 PPP2R3A PAX8 GLDC CACNA2D3 SAMD4A	8.18e-06	193	166	7	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SIM2 CDCP1 PPP2R3A PAX8 GLDC CACNA2D3 SAMD4A	8.18e-06	193	166	7	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 FREM1 PTPN13 PAX8 NBEAL2 STK33 ATP6V0A4	8.46e-06	194	166	7	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 FREM1 PTPN13 PAX8 NBEAL2 STK33 ATP6V0A4	8.46e-06	194	166	7	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SQLE PLXNB2 SMYD4 PTPN13 LMAN1 PLA2G4B ATP6V0A4	9.35e-06	197	166	7	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast\|ICU-NoSEP / Disease, condition lineage and cell class	CALU NEK1 LMAN1 GLDC STK33 SEL1L3 STEAP1	9.35e-06	197	166	7	8f35f9741086a38f0e594dce0547b575946f52bb
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SQLE CDCP1 PLXNB2 USP44 SMYD4 PTPN13 LMAN1	9.66e-06	198	166	7	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C MXRA5 FREM1 BMP4 CHSY3 LTBP2 CACNA2D3	1.03e-05	200	166	7	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	ASK454-Epithelial-Type_2\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	CDK17 CENPF MEGF8 ZNF41 LMLN SPAG16	1.22e-05	136	166	6	ff9a5e111993fdb3ac64c5ef269e3460ff994517
ToppCell	PBMC-Severe-cDC_3\|Severe / Compartment, Disease Groups and Clusters	ITPRIPL2 ZNF835 USP44 STK33 PWP2 CTF1	2.29e-05	152	166	6	1a3f8ed476aa9a39742b4684be2c704669e4a3d0
ToppCell	10x5'-blood-Lymphocytic_T_CD4-Trm_Th1/Th17\|blood / Manually curated celltypes from each tissue	COG7 SIAH2 ZNF619 PTPN13 ZNF888 SAMD4A	2.75e-05	157	166	6	c99cb26d831c25038f2aa1b1c0f7ba52facb2e7a
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TDRD9 CYSLTR1 ID2 IDI2 PTPN13 MAPKAPK3	3.39e-05	163	166	6	476e94e1d132eaaecb9e376bd32748a75ad22081
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	ZFP3 AMACR HECTD4 SMPDL3A LTBP2 SAMD4A	3.51e-05	164	166	6	d7053de88ef8e42cac6726a40e72f212659ee034
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF235 PARP14 TEK RIN1 ZNF770 TOR1B	3.88e-05	167	166	6	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF234 CUBN KANSL3 NEK1 STK33 LMLN	4.01e-05	168	166	6	ca94b29c1030484143a77f2df06dad74d2c6136e
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C GAD1 VPS13C CDCP1 LRFN4 USP38	4.88e-05	174	166	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	REXO4 MCM8 CNNM4 ZNF17 CCNE2 WDCP	5.71e-05	179	166	6	ec69e1dd897414033ba5b007aa82655a79adca6c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 FREM1 PTPN13 GLDC STK33 DOCK7	5.89e-05	180	166	6	788d5fbf688365b5d92d3aa19b9f8e9448f8be5a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GAD1 SIM1 FREM1 GLDC ATP6V0A4 CACNA2D3	6.26e-05	182	166	6	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIM1 CUBN PPP2R3A PAX8 GLDC CACNA2D3	6.26e-05	182	166	6	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	droplet-Kidney-nan-18m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ID2 CUBN STEAP2 PSME4 GLDC ATP6V0A4	6.65e-05	184	166	6	e02859bbac36dbbd55d7ae8cb5e46b764d7c6381
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma\|TCGA-Breast / Sample_Type by Project: Shred V9	ZNF597 CMKLR2 SIAH2 ZNF619 GRM5	6.83e-05	114	166	5	656072c25258d4c00f24f6ba17de6a5db891e7be
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PNPLA2 RPS6KA5 CNNM4 CCNT1 BMP4 DST	6.86e-05	185	166	6	87151ab95530e70d61328b336518df58db584acb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN13 PAX8 GLDC STK33 DOCK7 SPAG16	6.86e-05	185	166	6	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C CDK17 SPEG MICAL2 LTBP2 SAMD4A	6.86e-05	185	166	6	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SIM1 FREM1 PPP2R3A PTPN13 GLDC ATP6V0A4	7.06e-05	186	166	6	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DPP6 SIM2 PPP2R3A PAX8 SPAG16 CACNA2D3	7.28e-05	187	166	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	USP53 GAD1 SIM2 ATP6V0A4 LTBP2 CACNA2D3	7.28e-05	187	166	6	7ea8731288e2a99f45e3958590ee1d76f49ae888
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SIM1 SIM2 NUAK2 PAX8 SEL1L3 CACNA2D3	7.28e-05	187	166	6	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 PAX8 GLDC STK33 ATP6V0A4 DOCK7	7.28e-05	187	166	6	2d17408b3b5f09d135084fd7ccce98e6b5ca632b
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RALGAPA1 CDK17 VPS13C PARP14 RAPGEF2 MED13	7.49e-05	188	166	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COVID-19-kidney-DCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GAD1 SIM1 PPP2R3A PAX8 ATP6V0A4 CACNA2D3	7.49e-05	188	166	6	1d56cd409793f05cca20757ab26e91f1a1ee67b5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	USP53 GAD1 SIM1 SIM2 ATP6V0A4 CACNA2D3	7.72e-05	189	166	6	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 SH3TC1 GLDC STK33 ATP6V0A4 DOCK7	7.72e-05	189	166	6	532aaf02b364c5c4f58a2021c7c21d86df3875c9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SIM2 ADAM10 PPP2R3A PAX8 SEL1L3 CACNA2D3	8.18e-05	191	166	6	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SIM2 NUAK2 PPP2R3A PAX8 CACNA2D3 SAMD4A	8.18e-05	191	166	6	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	COVID-19-kidney-Mito-rich_Distal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIM1 SIM2 PPP2R3A PAX8 ATP6V0A4 CACNA2D3	8.18e-05	191	166	6	0965f621ebcd92ccdeb21cc27022180ce3cfe910
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SIM2 NUAK2 PPP2R3A PAX8 CACNA2D3 SAMD4A	8.18e-05	191	166	6	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 CACNA1C STEAP2 FREM1 DST LTBP2	8.18e-05	191	166	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	COVID-19-kidney-CNT\|kidney / Disease (COVID-19 only), tissue and cell type	MXRA5 CHSY1 SIM1 FREM1 PPP2R3A PTPN13	8.41e-05	192	166	6	d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GAD1 SIM1 SIM2 ATP6V0A4 LTBP2 CACNA2D3	8.41e-05	192	166	6	562df5e87038c500dd3a003fe5374cb31946b145
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 CHSY1 SH3TC1 MICAL2 SEL1L3 SAMD4A	8.41e-05	192	166	6	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SIM2 CDCP1 DST PAX8 CACNA2D3 SAMD4A	9.16e-05	195	166	6	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SIM2 CDCP1 DST PAX8 CACNA2D3 SAMD4A	9.16e-05	195	166	6	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 CACNA1C STEAP2 FREM1 DST AASS	9.42e-05	196	166	6	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CENPF VPS13C VPS13D PTPN13 LMLN CDC27	9.96e-05	198	166	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Epithelial_cells-AT1-AT2_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	MYO1C ARID4A DST INF2 NBEAL2 SAMD4A	9.96e-05	198	166	6	fbc46b20bcd44f2083170aacbc6f5dd00fba685c
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 CACNA1C STEAP2 DST AASS LTBP2	9.96e-05	198	166	6	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 CACNA1C STEAP2 DST AASS LTBP2	1.02e-04	199	166	6	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C STEAP2 FREM1 DST LTBP2 SAMD4A	1.05e-04	200	166	6	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	(5)_Fibroblasts\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MXRA5 ARID4A STEAP2 DST LTBP2 STEAP1	1.05e-04	200	166	6	22c839f27d3abdf86bfabdfa305f205dd899a9dc
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial\|10w / Sample Type, Dataset, Time_group, and Cell type.	ITPRIPL2 SIM1 SIM2 RIN1 LTBP2 SMCR8	1.05e-04	200	166	6	ff0b2675c68e9fc1fa16b3276431f199f3642eac
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	USP53 CACNA1C STEAP2 DST AASS LTBP2	1.05e-04	200	166	6	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	USP53 CACNA1C STEAP2 DST AASS LTBP2	1.05e-04	200	166	6	a510deaada669e690329183e18df02870bd204b3
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	ITPRIPL2 SIM1 SIM2 RIN1 LTBP2 SMCR8	1.05e-04	200	166	6	07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	USP53 CACNA1C STEAP2 FREM1 DST LTBP2	1.05e-04	200	166	6	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Fibroblast\|World / shred by cell class for parenchyma	MXRA5 ARID4A STEAP2 DST LTBP2 STEAP1	1.05e-04	200	166	6	dec9ce1bc2571197003596f32e5f742ede72aa79
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	USP53 CACNA1C STEAP2 FREM1 DST LTBP2	1.05e-04	200	166	6	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	USP53 CACNA1C STEAP2 DST AASS LTBP2	1.05e-04	200	166	6	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	(01)_Cycling_Basal_(homeostasis)-(3)_72hpi\|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint	VPS13C USP44 SAMD4A	1.51e-04	28	166	3	ef8053df22b28c772eb39c5e4033f96eb5aa54d9
Drug	Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A	KANSL3 CNNM4 BMP4 SLC9A5 SH3TC1 PAX8 MICAL2 NFKBIB CPLANE1 SAMD4A	1.30e-06	192	163	10	5101_UP
Drug	Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A	ATP13A1 SQLE PLXNB2 MAP3K5 CNNM4 RNF123 LRFN4 SEL1L3 CDC27 ARHGAP19	1.49e-06	195	163	10	1903_UP
Drug	semustine; Down 200; 100uM; PC3; HT_HG-U133A	RALGAPA1 CDK17 ZNF235 ADAM10 NUAK2 NEK1 CCNE2 SENP6 FGD6	1.14e-05	194	163	9	7545_DN
Drug	STOCK1N-35874; Down 200; 14uM; PC3; HT_HG-U133A	RALGAPA1 GAD1 RPS6KA5 ZNF230 PPP2R3A INF2 MARF1 ZNF552 SPAG16	1.29e-05	197	163	9	6561_DN
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	RALGAPA1 CENPF ZNF230 SH3TC1 ATP6V0A4 NFKBIB ZNF552 LTBP2 RAPGEF2	1.29e-05	197	163	9	2860_UP
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	GAD1 LUZP1 RIN1 VPS13D PSME4 WDCP NFKBIB ZNF552 ATM	1.34e-05	198	163	9	4703_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	RALGAPA1 GAD1 RPS6KA5 CAMK2G ID2 KANSL3 GLYR1 NFKBIB HSF2	1.34e-05	198	163	9	1002_UP
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A	GAD1 CENPF RIN1 NEK1 VPS13D PPP2R3A PSME4 SENP6 LTBP2	1.34e-05	198	163	9	4808_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	CDK17 CLK4 SQLE CHSY1 CCNE2 RAPGEF2 MED13 SAMD4A	5.81e-05	185	163	8	1114_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	TUT7 HECTD4 MAP3K5 VPS13D PPP2R3A MICAL2 CCNE2 ATM	5.81e-05	185	163	8	4755_DN
Drug	5182598; Down 200; 25uM; MCF7; HT_HG-U133A_EA	RPS6KA5 ABHD10 MAP3K5 NUAK2 BMP4 NEK1 PPP2R3A SMPDL3A	6.26e-05	187	163	8	868_DN
Drug	Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A	GAD1 RPS6KA5 MAP3K5 BMP4 PPP2R3A PSME4 SENP6 RAPGEF2	6.75e-05	189	163	8	4401_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	SQLE MAP3K5 VPS13D PPP2R3A PSME4 CCNE2 SENP6 MED13	7.00e-05	190	163	8	2619_DN
Drug	Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; PC3; HT_HG-U133A	CDK17 CALU SQLE ZNF230 MAP3K5 PPP2R3A LMAN1 CCNE2	7.81e-05	193	163	8	4596_DN
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A	CDK17 COG7 VPS13C ADAM10 LUZP1 VPS13D LMAN1 CLK3	8.10e-05	194	163	8	1405_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	SQLE SIM2 NEK1 PPP2R3A PSME4 GLYR1 NFKBIB CDC27	8.10e-05	194	163	8	4361_DN
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A	CDK17 CAMK2G ADAM10 LUZP1 VPS13D LMAN1 GLYR1 NFKBIB	8.40e-05	195	163	8	3909_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A	MAP3K5 NEK1 LMAN1 SH3TC1 GLYR1 ATP6V0A4 NFKBIB RAPGEF2	8.40e-05	195	163	8	3835_DN
Drug	Piperine [94-62-2]; Down 200; 14uM; HL60; HT_HG-U133A	PNPLA2 ADAM10 LMAN1 INF2 PAX8 CCNE2 ZNF552 HSF2	8.70e-05	196	163	8	1327_DN
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; HL60; HT_HG-U133A	SQLE NUAK2 LRFN4 LMAN1 MEGF8 INF2 ZNF552 LTBP2	8.70e-05	196	163	8	2372_DN
Drug	Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; PC3; HT_HG-U133A	CDK17 NUAK2 RIN1 INF2 AASS GLYR1 CPLANE1 HSF2	9.01e-05	197	163	8	7148_UP
Drug	Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CAMK2G NEK1 PPP2R3A LRFN4 LMAN1 INF2 SMPDL3A SENP6	9.01e-05	197	163	8	2860_DN
Drug	Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A	CMKLR2 MXRA5 CENPF SPEG CDCP1 TEK SH3TC1 PAX8	9.01e-05	197	163	8	4152_UP
Drug	Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A	CAMK2G SQLE NEK1 PTPN13 LMAN1 INF2 CCNE2 NFKBIB	9.01e-05	197	163	8	4613_DN
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	RALGAPA1 GAD1 MYO1C CAMK2G SPEG VPS13D MEGF8 ATM	9.01e-05	197	163	8	4690_UP
Drug	Ascorbic acid [50-81-7]; Down 200; 22.4uM; MCF7; HT_HG-U133A	PNPLA2 LUZP1 BMP4 NEK1 NBEAL2 NFKBIB AIPL1 ZNF552	9.01e-05	197	163	8	3225_DN
Drug	Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A	CALU SQLE CCNT1 NEK1 PPP2R3A LMAN1 PSME4 NBEAL2	9.01e-05	197	163	8	2095_DN
Drug	Fluorometholone [426-13-1]; Down 200; 10.6uM; PC3; HT_HG-U133A	CDK17 CENPF COG7 ID2 NEK1 LMAN1 ATM HSF2	9.01e-05	197	163	8	5771_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	CMKLR2 SPEG LUZP1 CCNT1 BMP4 SENP6 SPAG16 HSF2	9.34e-05	198	163	8	1237_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CCNT1 VPS13D PPP2R3A PSME4 INF2 MAPKAPK3 ATM SAMD4A	9.34e-05	198	163	8	1070_DN
Drug	Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; MCF7; HT_HG-U133A	MXRA5 AMACR VPS13C ZNF235 PPP2R3A ADAMTS7 LTBP2 CPLANE1	9.34e-05	198	163	8	3170_UP
Drug	Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A	GAD1 CENPF RNF17 LUZP1 LMAN1 AASS GLYR1 ATP6V0A4	9.34e-05	198	163	8	5416_UP
Drug	Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A	CENPF SIM2 MAP3K5 NUAK2 CLK3 GLYR1 SENP6 ATM	9.34e-05	198	163	8	7328_DN
Disease	autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)	VPS13C VPS13D	8.30e-05	3	156	2	DOID:0111611 (implicated_via_orthology)
Disease	GLAUCOMA 3, PRIMARY INFANTILE, B	TEK LTBP2	8.30e-05	3	156	2	600975
Disease	GLAUCOMA 3, PRIMARY INFANTILE, B	TEK LTBP2	8.30e-05	3	156	2	C1832977
Disease	Glaucoma 3, primary infantile, B	TEK LTBP2	8.30e-05	3	156	2	cv:C1832977
Disease	Hydrophthalmos	TEK LTBP2	2.75e-04	5	156	2	C0020302
Disease	Ciliopathies	RDH12 TSC1 NEK1 AIPL1 CPLANE1	3.03e-04	110	156	5	C4277690
Disease	Polydactyly	CENPF BMP4 NEK1 MEGF8 CPLANE1	4.03e-04	117	156	5	C0152427
Disease	methylcobalamin deficiency type cblE, cytotoxicity measurement	AIPL1 CHSY3	4.11e-04	6	156	2	EFO_0006952, MONDO_0009354
Disease	atrioventricular septal defect (implicated_via_orthology)	BMP4 GLYR1	5.73e-04	7	156	2	DOID:0050651 (implicated_via_orthology)
Disease	Unilateral agenesis of kidney	FREM1 BMP4	7.62e-04	8	156	2	C0266294
Disease	Disorder of eye	RDH12 FREM1 CNNM4 BMP4 AIPL1 CPLANE1	9.52e-04	212	156	6	C0015397
Disease	acoustic startle blink response measurement	CACNA1C PARP14	9.76e-04	9	156	2	EFO_0006875
Disease	nitric oxide exhalation measurement	CACNA1C DLEC1 CACNA2D3	1.07e-03	38	156	3	EFO_0005536
Disease	response to antihypertensive drug	DPP6 HECTD4 RAPGEF2	1.33e-03	41	156	3	EFO_0005405
Disease	response to statin, myopathy	RASGRF2 CDCP1	1.48e-03	11	156	2	EFO_0004145, GO_0036273
Disease	Malignant neoplasm of breast	RASGRF2 CENPF MYOD1 SIM1 CUBN TEK ADAM10 CNNM4 BMP4 ZNF532 WDCP DLEC1 ATM CDC27	1.74e-03	1074	156	14	C0006142
Disease	Gastric Adenocarcinoma	SPEG MLH1 ATM	1.75e-03	45	156	3	C0278701
Disease	Prenatal Exposure Delayed Effects	MYOD1 ATM	1.77e-03	12	156	2	C0033054
Disease	Neoplasm of uncertain or unknown behavior of bladder	TSC1 ATM	2.79e-03	15	156	2	C0496930
Disease	Dyskinesia, Medication-Induced	GAD1 RASGRF1	2.79e-03	15	156	2	C0751088
Disease	gamma-glutamylphenylalanine measurement	DPP6 TEK	2.79e-03	15	156	2	EFO_0021142
Disease	Proteinuria	CUBN ADAMTS7	2.79e-03	15	156	2	HP_0000093
Disease	Benign neoplasm of bladder	TSC1 ATM	2.79e-03	15	156	2	C0154017
Disease	Carcinoma in situ of bladder	TSC1 ATM	2.79e-03	15	156	2	C0154091
Disease	Dyskinesia, Drug-Induced	GAD1 RASGRF1	2.79e-03	15	156	2	C0013386
Disease	Leber congenital amaurosis	RDH12 AIPL1	3.17e-03	16	156	2	cv:C0339527
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	TSC1 NEK1	3.17e-03	16	156	2	DOID:0110861 (implicated_via_orthology)
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	CAMK2G MED13	3.59e-03	17	156	2	DOID:0060307 (is_implicated_in)
Disease	Carcinoma of bladder	TSC1 ATM	4.02e-03	18	156	2	C0699885
Disease	obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa	CACNA1C THOC7 VPS45 CNNM4 SPAG16	4.30e-03	200	156	5	EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Disease	Congenital hernia of foramen of Morgagni	MYOD1 FREM1	4.48e-03	19	156	2	C0265699
Disease	Congenital hernia of foramen of Bochdalek	MYOD1 FREM1	4.48e-03	19	156	2	C0265700
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	MLH1 ATM	4.48e-03	19	156	2	C1333991

Protein segments in the cluster

Peptide	Gene	Start	Entry
KHHHSQEIIEFPAVL	ERI2	51	A8K979
ALLPHLHEHNLVKVT	COG7	331	P83436
EHTSDILRHHPGIVK	AIPL1	251	Q9NZN9
QFRTVHHHEPKVKEE	ARID4A	406	P29374
PHLEAKIRQTHSLAH	CTF1	21	Q16619
HVPPKVSHITFAHEV	ADAM10	371	O14672
IPLLQDHFTLQHTHI	ADAM21	571	Q9UKJ8
LDEDVLPKPSFHHHS	CDCP1	621	Q9H5V8
PVLTFEEVVHHDHNK	AMACR	296	Q9UHK6
HVAQELHFIEKAHTL	ATP13A1	756	Q9HD20
HPSGHLEHKTIDLVA	AASS	846	Q9UDR5
HDKHFEVLHSDLEPQ	CCNE2	126	O96020
DLHTATPLDFLHIFH	CCNI	141	Q14094
FLHENQLTHTDLKPE	CLK3	421	P49761
DRVHHEPQLSDKVHN	CALU	26	O43852
FELTIDHPHTHVVKC	CCNT1	146	O60563
TVRSFHHEEHLENIP	BMP4	116	P12644
HPLHHDTAILLTRKD	ADAMTS7	331	Q9UKP4
TEQLHELEKIFHFTH	ISX	91	Q2M1V0
KHLRTDAFSQHHLEP	PAX8	221	Q06710
VAHHIGKIPFHDLQS	RDH12	176	Q96NR8
SFLLKVLPADSHEHA	PNPLA2	96	Q96AD5
DPTFHTHQLHLVDLR	KIAA0100	1441	Q14667
LNVSHNHISHIPKEI	LRRD1	216	A4D1F6
FSVHHQPTVDKVHER	GRM5	41	P41594
FLHSHNIAHRDVKPE	MAPKAPK3	156	Q16644
VQPEPFFHKVVHSEH	NEK1	981	Q96PY6
FFHKVVHSEHLNLVP	NEK1	986	Q96PY6
TPNEHHDHLLSEHVI	MCM8	596	Q9UJA3
ELLTHIPRHKLNTFH	HECA	351	Q9UBI9
LIRIHAEPVIHFHKT	SBF2	376	Q86WG5
LPSVESHLENHKNVH	DST	631	Q03001
LHLDPTYHITDDHTK	SMPDL3A	46	Q92484
HPKIIHESGAQILRH	ASPDH	76	A6ND91
HHVPSDTEVINKVHL	LMLN	66	Q96KR4
TFDRSTKVLDFHHPH	GAD1	131	Q99259
TKVLDFHHPHQLLEG	GAD1	136	Q99259
ALHLAVIHQHEPFLD	NFKBIB	61	Q15653
NILKNPHFIFDVHVH	PLXNB2	1691	O15031
LLKPEEHSHFPAAVH	MYOD1	56	P15172
FLELQTASDPDLHHK	FAM205A	721	Q6ZU69
DGHHSIRHKFPINVL	FREM1	501	Q5H8C1
HFHHFLLSQTEKPAV	GLYR1	216	Q49A26
LVITYPHEHHALKSS	MEGF8	2596	Q7Z7M0
ETTQHFIDIKEHLHI	LMAN1	431	P49257
EGHPNIVKLHEVFHD	RPS6KA5	476	O75582
IVKLHEVFHDQLHTF	RPS6KA5	481	O75582
KHANIVTLHDIVHTD	CDK17	246	Q00537
NEALLHDEPHDHKLS	PLA2G4B	406	P0C869
ITSVLGKQHPIEAHH	HECTD4	251	Q9Y4D8
EHRAEFPEHATHLKK	PPP2R3A	446	Q06190
LHHVLEEAEKSHPDL	INF2	801	Q27J81
EVHFLLHPSDHENIQ	PARP14	1166	Q460N5
PNHLIHLMFETFHLE	CUBN	966	O60494
DHPHHTLFIILALAN	ATM	2551	Q13315
HLDDVTPFVELHKIH	IDI2	211	Q9BXS1
DISQKTVLPLHLVHH	CACNA1C	1996	Q13936
LPATLTDHHHLLFTF	DOCK7	636	Q96N67
FLSLQSEHKILHDQH	CENPF	1411	P49454
TIPSEIHKILHESHN	CPLANE1	3121	Q9H799
HPEHRHLSQLEAIKL	CACNA2D3	661	Q8IZS8
HLKEPFLEATDNSHL	SQLE	371	Q14534
NHVSSPFELSIHKHD	LUZP1	836	Q86V48
LASVNPSLVKVHIHH	LTBP2	466	Q14767
HLEEHISQSELTPHL	MARF1	236	Q9Y4F3
AVRSKVLEIHSHFPH	KANSL3	331	Q9P2N6
FLHHNKLTHTDLKPE	CLK4	276	Q9HAZ1
IIHPTADEKIHFQHT	DPP6	786	P42658
LAQSEEKPHVVAHFH	GYS1	166	P13807
EHLHAQTDFLPSIEK	CEP295	1461	Q9C0D2
ELEHIFPNLHHQLFK	CEP295	2066	Q9C0D2
HTQEELTHLALPCHV	DLEC1	1041	Q9Y238
HIHPSSALHEQETKL	DHX40	651	Q8IX18
LPKLHEFNAHDLSSV	DHX40	696	Q8IX18
CKEAINILSHLPSHH	CDC27	481	P30260
HIHQHDIVHRDLKPE	CAMK2G	126	Q13555
PHQVKHLYITKELEH	MICAL2	481	O94851
DKYHIHHISEPTRQE	PTPN13	1751	Q12923
NLFQHIVKEPTDNHH	HSF2	211	Q03933
LTEHEHFHTREKPFE	ZNF146	31	Q15072
EHEVRLSPHVLGHSK	ITPRIPL2	106	Q3MIP1
HPDLIQQIIKKHFAH	FBXL21P	101	Q9UKT6
TLEKLPTFDLASHHH	MAP3K5	336	Q99683
HALHNDLKVLFLDHP	REXO4	326	Q9GZR2
LPRAIHHAATHKELE	RIN1	161	Q13671
PHHILDFLEIDSTLH	SEL1L3	1001	Q68CR1
FNLLPHTENHSPEHK	SMYD4	426	Q8IYR2
KHEHIIHLEQVFETP	STK33	171	Q9BYT3
EHIHHSKLSPHLLEE	TDRD9	331	Q8NDG6
HELLAHTPHEHVERK	RASGRF2	396	O14827
HTPHEHVERKSLEFA	RASGRF2	401	O14827
KLVPNHHFDPHLEAS	NBEAL2	1841	Q6ZNJ1
QIALDSHPTIVSLHH	ID2	76	Q02363
EPQDLIEKTLYHHVH	SIM2	256	Q14190
EPQDLIEKTLYHHVH	SIM1	256	P81133
SLTLHHTEKPEHEDI	SIAH2	146	O43255
SEHHKPTLNQELHEH	SLC9A5	461	Q14940
PTLNQELHEHTFDHI	SLC9A5	466	Q14940
LARHHVHLKQPEEAL	SH3TC1	671	Q8TE82
PHVVDVTHHEDALTK	STEAP2	71	Q8NFT2
HLHVPSVQSDELLHS	MED13	2101	Q9UHV7
SVQSDELLHSKHSHP	MED13	2106	Q9UHV7
SLNHPHIIAIHEVFE	NUAK2	106	Q9H093
FVLHHDQTPESHILK	TEX45	301	Q8NA69
HVPHEKLQSHVTLGE	TEX45	346	Q8NA69
NVHPTKHEVHFLHEE	MLH1	306	P40692
TLHELLAHTPHEHVE	RASGRF1	391	Q13972
HLHLPTHDKETEELV	SMCR8	866	Q8TEV9
PVLLHLHQTAHADEF	STEAP1	41	Q9UHE8
FIKEAEHHCLLHSPI	ABHD10	221	Q9NUJ1
FQKHDPDLTLIRHHV	CMKLR2	191	P46091
DLHNSKIHQAITLHP	CHSY1	291	Q86X52
DLHNSKIHAAITLHP	CHSY3	381	Q70JA7
HLHFLHNETKPCDSV	CYSLTR1	256	Q9Y271
NHPVHFVFHDTKLDA	CNNM4	446	Q6P4Q7
HEFHPESHLQIKNHL	USP53	766	Q70EK8
VVDTHVRPEHSAKQH	RNF17	531	Q9BXT8
RKPVFHLSHEERVQH	XPR1	111	Q9UBH6
TKLHLTDSLHPQVTH	RAPGEF2	26	Q9Y4G8
LLQFHEHIPQHKSDG	ZNF532	1186	Q9HCE3
IKDHEHTDPHVQQIA	ZYG11B	701	Q9C0D3
HVRIHPELVTGSKDH	TSC1	226	Q92574
HLFEVALPKTAHHFV	TSC1	606	Q92574
QLIHHQETHSGLKPF	ZNF497	176	Q6ZNH5
VLLELVEHHLTPKSH	TNFAIP8L2	126	Q6P589
LLHHSAIPEDFLHIF	LINC00052	6	Q96N35
VHESHHPQIKEALNV	RALGAPA1	1306	Q6GYQ0
HQSHVLHLDVKPENL	SPEG	1711	Q15772
IFHLHELPEFNLIHS	PWP2	311	Q15269
PTVLLTLAHIFHHFA	RNF123	311	Q5XPI4
VKHLHIHTPLLDSER	RIPK2	46	O43353
ASYEPTIRVLHEKHH	SPAG16	221	Q8N0X2
SFEKVPDHHSCHLQL	FGD6	231	Q6ZV73
RFHHAHAQIPVVKTA	SENP6	136	Q9GZR1
HFVTTAPTLKLLNHH	SEZ6	56	Q53EL9
HQPFLHETLDHLIKG	VPS45	466	Q9NRW7
EHFHISPVKLHLSLS	VPS13C	3326	Q709C8
ELPEPLLTHKHFNAH	ARHGAP19	186	Q14CB8
ALAKVIQHHPDRHET	THOC7	121	Q6I9Y2
IQHHPDRHETLKELE	THOC7	126	Q6I9Y2
TVLHPKDFNHTDHFS	TEK	391	Q02763
KPHLEHLVADSHEST	PSME4	1361	Q14997
EAFHLIVPHVVNLVH	USP38	346	Q8NB14
THLKIHQLTHSEERP	ZNF770	201	Q6IQ21
HLLTHQRVHSGEKPF	ZNF234	526	Q14588
HLVNHLRVHTGEKPF	ZNF697	451	Q5TEC3
FDVHVSQHAPSILIH	ATP6V0A4	601	Q9HBG4
HLAQHTRIHTGEKPF	ZNF888	676	P0CJ79
SHLFLHLHTLQPEDS	TRBV4-3	91	A0A589
SHLLRHQIIHTGEKP	ZNF70	181	Q9UC06
HKQAPTHHQKIHPEE	ZNF41	296	P51814
SHLLVHQRIHTGEKP	ZNF552	281	Q9H707
LKDILHLAEHQTTHP	ZNF792	141	Q3KQV3
GFTDSLDLHKHQIIH	ZNF230	316	Q9UIE0
QLVFTHEDLPTLSHH	ZNF566	141	Q969W8
LIQHHIVHTGEKPYE	ZNF835	461	Q9Y2P0
FTHKPLLSSHFDQHL	ZNF687	836	Q8N1G0
SHLPELHIFHTEEKI	ZNF765	146	Q7L2R6
QHILLTDHIHTAEKP	ZNF713	246	Q8N859
LISHQNIHTEERPHK	ZNF597	356	Q96LX8
EPLDLTHIHFNQHKS	WDCP	281	Q9H6R7
SEHSKEVINHHPDVQ	TUT7	651	Q5VYS8
SHLFLHLHTLQPEDS	TRBV4-2	91	A0A539
SDFHLHQRVHTNEKP	ZNF619	201	Q8N2I2
SHLQAHERIHTGEKP	ZNF235	416	Q14590
ILHLAEHQETHPGQK	ZNF772	156	Q68DY9
PKILAHSIEHNQHIE	SAMD4A	106	Q9UPU9
THEPLVDTHLQHLKS	TBRG1	386	Q3YBR2
HALKHFQESSHPVAL	USP44	56	Q9H0E7
ILHLAEHDGTHPKRT	ZNF17	96	P17021
FLTQAHLVGHQKIHT	ZNF17	311	P17021
SHLLIHQRVHTGEKP	ZNF214	511	Q9UL59
VHLFVSTLHFPHEQK	TOR1B	136	O14657
DLILHEQIHSGEKPH	ZNF311	261	Q5JNZ3
SHFTQDLHPEQGIKH	ZNF722	91	A0A1W2PQL4
SHLIVHQRIHTGEKP	ZFP3	406	Q96NJ6
ELTEHQRIHTGIKPH	ZNF649	276	Q9BS31
HDFLHTPSDIKKQNH	VPS13D	2411	Q5THJ4
DVSHLNLHKTFCIPH	GLDC	746	P23378
IVPASSHHFLLKHLV	LRFN4	451	Q6PJG9
EKLEDTVKHHPHFLT	MYO1C	511	O00159
RLHIDHNKIEFIHPQ	MXRA5	131	Q9NR99